Skip to main content

Table 2 Cardiometabolic Risk Parameters at Baseline and 12 Months by Randomization Group

From: Embedding weight management into safety-net pediatric primary care: randomized controlled trial

Cardiometabolic Risk Parameters Standard-of-Care Alone (n = 182) Standard-of-Care + Enhanced Program (n = 178) Difference in mean slope /12 monthsa Difference in mean slopea Overall group differencea
Baseline 12 Months p-valueb Baseline 12 Months p-valueb Experimental - Control ±SE p-value p-value
Systolic blood pressure, mean (SD), mmHg 106.6 (10.2) 107.1 (12.9) 0.37 106.7 (11.1) 107.9 (12.3) 0.13 0.59 ± 1.36 0.67 0.87
Diastolic blood pressure, mean (SD), mmHg 58.7 (5.5) 58.8 (5.9) 0.94 58.1 (5.7) 58.0 (5.6) 0.87 −0.05 ± 0.74 0.94 0.38
Fasting Glucose, mean (SD), mmol/L 4.7 (0. 6) 4.8 (0.4) 0.19 4.7 (0.5) 4.8 (0.4) 0.13 −0.02 ± 0.06 0.70 0.65
2 Hour Glucose, mean (SD), mmol/L 5.4 (1.0) 5.66 (1.1) 0.11 5.4 (1.0) 5.4 (1.0) 0.74 −0.14 ± 0.13 0.25 0.18
Total Cholesterol, mean (SD), mmol/L 4.09 (0.77) 4.15 (0.75) 0.60 3.98 (0.69) 3.87 (0.69) 0.19 −0.1 ± 0.06 0.10 0.05
HDL Cholesterol, mean (SD), mmol/L 1.19 (0.24) 1.24 (0.27) 0.28 1.19 (0.26) 1.23 (0.30) 0.02 0.01 ± 0.02 0.48 0.67
LDL Cholesterol, mean (SD), mmol/L 2.46 (0.59) 2.41 (0.61) 0.07 2.35 (0.60) 2.18 (0.56) 0.01 −07 ± 0.05 0.11 0.04
Triglycerides, mean (SD), mmol/L 1.02 (0.71) 1.11 (0.61) 0.01 0.94 (0.49) 1.01 (0.56) 0.09 −0.06 ± 0.06 0.34 0.08
AST, mean (SD), ukat/L 0.50 (0.12) 0.45 (0.23) 0.01 c 0.53 (0.19) 0.40 (0.19) 0.01c −0.08 ± 0.03 0.01 0.02
ALT, mean (SD), ukat/L 0.41 (0.19) 0.45 (0.23) 0.15 0.45 (0.37) 0.40 (0.19) 0.01 c −0.08 ± 0.03 0.01 0.03
  1. aBased on covariance pattern model and adjusted for child’s age, sex and ethnicity
  2. bPaired t-test
  3. cWilcoxon sign rank test
  4. HDL, High-density lipoprotein, LDL, Low-density lipoprotein, ALT, alanine transaminase, AST, aspartate aminotransferase